SHOX2 and atrial fibrillation: We demonstrated that a novel hsa-miR-92b-5p target site generated by a genetic variant in the 3′UTR of the SHOX2 gene may reduce SHOX2 expression and thereby facilitate proarrythmogenic remodeling leading to AF.